Allianz Asset Management
IRWD icon

Allianz Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Allianz Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-293,100
Closed -$431K – 2158
2025
Q1 		$431K Buy
293,100
+235,800
+412% +$562K ﹤0.01% 1922
2024
Q4 		$254K Buy
+57,300
New +$232K ﹤0.01% 2048
2023
Q4 		– Sell
-41,000
Closed -$395K – 2188
2023
Q3 		$395K Hold
41,000
– – ﹤0.01% 2006
2023
Q2 		$436K Buy
+41,000
New +$441K ﹤0.01% 1769
2021
Q4 		– Sell
-23,060
Closed -$301K – 2615
2021
Q3 		$301K Sell
23,060
-37,413
-62% -$484K ﹤0.01% 2409
2021
Q2 		$778K Sell
60,473
-10,945
-15% -$125K ﹤0.01% 1849
2021
Q1 		$798K Buy
71,418
+18,753
+36% +$198K ﹤0.01% 1729
2020
Q4 		$600K Buy
+52,665
New +$576K ﹤0.01% 1594
2020
Q3 		– Sell
-25,611
Closed -$265K – 2125
2020
Q2 		$265K Sell
25,611
-819
-3% -$8.38K ﹤0.01% 2225
2020
Q1 		$267K Sell
26,430
-614
-2% -$7.22K ﹤0.01% 2244
2019
Q4 		$360K Buy
+27,044
New +$298K ﹤0.01% 2519
2017
Q4 		– Sell
-16,459
Closed -$217K – 2698
2017
Q3 		$217K Sell
16,459
-4,603
-22% -$63.3K ﹤0.01% 2570
2017
Q2 		$333K Buy
+21,062
New +$306K ﹤0.01% 2488
2015
Q3 		– Sell
-199,846
Closed -$2.02M – 2368
2015
Q2 		$2.02M Sell
199,846
-127,012
-39% -$1.48M ﹤0.01% 1702
2015
Q1 		$4.38M Hold
326,858
– – 0.01% 1258
2014
Q4 		$4.19M Buy
326,858
+142,534
+77% +$1.63M ﹤0.01% 1276
2014
Q3 		$2M Hold
184,324
– – ﹤0.01% 1424
2014
Q2 		$2.37M Sell
184,324
-14,716
-7% -$160K ﹤0.01% 1143
2014
Q1 		$2.05M Buy
199,040
+41,790
+27% +$470K ﹤0.01% 1195
2013
Q4 		$1.53M Sell
157,250
-45,372
-22% -$407K ﹤0.01% 1285
2013
Q3 		$2.01M Buy
202,622
+9,552
+5% +$93.7K ﹤0.01% 1185
2013
Q2 		$1.61M Buy
+193,070
New +$2.34M ﹤0.01% 1245

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Allianz Asset Management's IRWD Position: Q2 2025 in Review

Allianz Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 293,100 shares — an estimated $431K sold.

Allianz Asset Management first reported a position in IRWD in Q2 2013 and held it in 22 quarters. The position peaked at $4.38M in Q1 2015. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Allianz Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Allianz Asset Management sold 293,100 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $431K.
  • Allianz Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • Allianz Asset Management's Ironwood Pharmaceuticals position peaked at $4.38M in Q1 2015.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.